Moncef Slaoui joins board at mRNA biotech; Gamida Cell retools with ex-Amryt CEO at the helm

Moncef Slaoui

Moncef Slaoui has reemerged this week with another board appointment, making his way to mRNA drug developer Arcturus Therapeutics. Endpoints News scooped you last September on Slaoui’s board seat with Altesa BioSciences, an antiviral startup with former HHS official Brett Giroir as CEO. Slaoui had just finished his work with Operation Warp Speed when sexual harassment allegations led to his dismissal from multiple positions in 2021, including his role as CFO of Centessa Pharmaceuticals. After Slaoui didn’t respond to calls for the Altesa story, Giroir vouched for his addition to the board, writing in an email that Slaoui “literally saved the world” during the Covid-19 pandemic.

Arcturus’ stock $ARCT soared in late May when it…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks